Literature DB >> 33489081

Social Symptoms of Parkinson's Disease.

Margaret T M Prenger1,2, Racheal Madray1, Kathryne Van Hedger2,3,4, Mimma Anello3, Penny A MacDonald2,3.   

Abstract

Parkinson's disease (PD) is typically well recognized by its characteristic motor symptoms (e.g., bradykinesia, rigidity, and tremor). The cognitive symptoms of PD are increasingly being acknowledged by clinicians and researchers alike. However, PD also involves a host of emotional and communicative changes which can cause major disruptions to social functioning. These incude problems producing emotional facial expressions (i.e., facial masking) and emotional speech (i.e., dysarthria), as well as difficulties recognizing the verbal and nonverbal emotional cues of others. These social symptoms of PD can result in severe negative social consequences, including stigma, dehumanization, and loneliness, which might affect quality of life to an even greater extent than more well-recognized motor or cognitive symptoms. It is, therefore, imperative that researchers and clinicans become aware of these potential social symptoms and their negative effects, in order to properly investigate and manage the socioemotional aspects of PD. This narrative review provides an examination of the current research surrounding some of the most common social symptoms of PD and their related social consequences and argues that proactively and adequately addressing these issues might improve disease outcomes.
Copyright © 2020 Margaret T. M. Prenger et al.

Entities:  

Year:  2020        PMID: 33489081      PMCID: PMC7790585          DOI: 10.1155/2020/8846544

Source DB:  PubMed          Journal:  Parkinsons Dis        ISSN: 2042-0080


  117 in total

1.  Comprehension of prosody in Parkinson's disease.

Authors:  A J Lloyd
Journal:  Cortex       Date:  1999-06       Impact factor: 4.027

2.  Evolutionary origins of stigmatization: the functions of social exclusion.

Authors:  R Kurzban; M R Leary
Journal:  Psychol Bull       Date:  2001-03       Impact factor: 17.737

3.  Recognition of emotion from facial, prosodic and written verbal stimuli in Parkinson's disease.

Authors:  Yayoi Kan; Mitsuru Kawamura; Yukihiro Hasegawa; Satoshi Mochizuki; Katsuki Nakamura
Journal:  Cortex       Date:  2002-09       Impact factor: 4.027

4.  The cognitive competence of speakers with acquired dysarthria: judgements by doctors and speech and language therapists.

Authors:  A Fox; T Pring
Journal:  Disabil Rehabil       Date:  2005-12-15       Impact factor: 3.033

5.  Facial expression decoding in early Parkinson's disease.

Authors:  Marc D Pell; Carol L Leonard
Journal:  Brain Res Cogn Brain Res       Date:  2005-01-07

6.  Facial expression recognition in people with medicated and unmedicated Parkinson's disease.

Authors:  R Sprengelmeyer; A W Young; K Mahn; U Schroeder; D Woitalla; T Büttner; W Kuhn; H Przuntek
Journal:  Neuropsychologia       Date:  2003       Impact factor: 3.139

7.  Mental symptoms in Parkinson's disease are important contributors to caregiver distress.

Authors:  D Aarsland; J P Larsen; K Karlsen; N G Lim; E Tandberg
Journal:  Int J Geriatr Psychiatry       Date:  1999-10       Impact factor: 3.485

8.  Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.

Authors:  Daniel Kempler; Diana Van Lancker
Journal:  Brain Lang       Date:  2002-03       Impact factor: 2.381

9.  Vocal emotion processing in Parkinson's disease: reduced sensitivity to negative emotions.

Authors:  Chinar Dara; Laura Monetta; Marc D Pell
Journal:  Brain Res       Date:  2007-10-22       Impact factor: 3.252

10.  Facial Emotion Recognition in Parkinson's Disease: An fMRI Investigation.

Authors:  Albert Wabnegger; Rottraut Ille; Petra Schwingenschuh; Petra Katschnig-Winter; Mariella Kögl-Wallner; Karoline Wenzel; Anne Schienle
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

View more
  5 in total

Review 1.  Novel Pharmacotherapies in Parkinson's Disease.

Authors:  Yousef Tizabi; Bruk Getachew; Michael Aschner
Journal:  Neurotox Res       Date:  2021-05-18       Impact factor: 3.911

2.  Stigma in Parkinson's disease: Placing it outside the body.

Authors:  Tomás de la Rosa; Fúlvio Alexandre Scorza
Journal:  Clinics (Sao Paulo)       Date:  2022-02-13       Impact factor: 2.365

3.  Association between Parkinson's Disease and Psychosocial Factors: Results of the Nationally Representative German Ageing Survey.

Authors:  Regina Vardanyan; Hans-Helmut König; André Hajek
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

4.  Like a Wave in Its Variable Shape, Breadth, and Depth: A Qualitative Interview Study of Experiences of Daytime Sleepiness in People with Parkinson's Disease.

Authors:  Arja Höglund; Peter Hagell; Ulrika Östlund; Sten Fredrikson; Christina Sandlund
Journal:  Parkinsons Dis       Date:  2022-09-27

5.  Rasagiline, sleep quality and well-being in Parkinson's disease: a pilot study.

Authors:  Carlotta Mutti; Roberta Beatrice Sarnataro; Jessica Beretta; Poli Enzo; Anna Negrotti; Francesco Rausa; Silvia Pizzarotti; Liborio Parrino
Journal:  Neurol Sci       Date:  2022-03-25       Impact factor: 3.830

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.